Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
32 hedge funds and large institutions have $20.9M invested in Intermolecular, Inc. in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
14% more funds holding
Funds holding: 28 → 32 (+4)
9% less capital invested
Capital invested by funds: $22.8M → $20.9M (-$1.94M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Emancipation Management
New York
|
+$410K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$343K |
| 3 |
JP Morgan Chase
New York
|
+$329K |
| 4 |
PCM
Prelude Capital Management
New York
|
+$157K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$168K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$150K |
| 3 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$19K |
| 4 |
HK
Horizon Kinetics
New York
|
-$10.8K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$10K |
IMI Hedge Fund Activity: Q4 2018 in Review
32 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q4 2018, worth a combined $20.9M — down 8.5% from $22.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IMI positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Emancipation Management, adding an estimated $410K. The largest seller was Bridgeway Capital Management, cutting an estimated $168K.
- 32 institutional investors held Intermolecular, Inc. (IMI) as of Q4 2018, up from 28 in Q3 2018.
- Funds reported $20.9M of Intermolecular, Inc. stock for Q4 2018, down 8.5% quarter-over-quarter.
- 7 funds opened new Intermolecular, Inc. positions in Q4 2018 and 3 closed out, a net change of +4 holders.
- The largest Intermolecular, Inc. buyer in Q4 2018 was Emancipation Management, an estimated $410K added.
- The largest Intermolecular, Inc. seller in Q4 2018 was Bridgeway Capital Management, an estimated $168K sold.
Based on aggregated 13F filings for Q4 2018.